| 摘要 |
<p>Disclosed is an EP1 antagonist, particularly a compound represented by the general formula (I), a salt thereof, a solvate of the compound or the salt, or a prodrug of the compound, the salt or the solvate. The compound is effective for the prevention or treatment of urinary excretion disorder and/or the amelioration of a condition associated with urinary excretion disorder (e.g., slowing of urinary stream, division of urinary stream, interruption of urinary stream, delayed urination, straining at urination, terminal dribbling). (I) wherein all symbols are as defined in the description.</p> |
